Description: Polarean Imaging plc operates as a drug-device manufacturer and service provider for noble gas polariser devices in Canada, the United Kingdom, and the United States. It engages in the research, development, and commercialization of novel imaging solutions with a non-invasive and radiation-free functional imaging platform. The company also offers XENOVIEW, a hyperpolarized contrast agent indicated for use with magnetic resonance imaging (MRI) for evaluation of lung ventilation in adults and pediatric patients aged 12 years and older; and measurement station, chest coil, and dose delivery inhalation bags. Polarean Imaging plc was incorporated in 2016 and is based in London, the United Kingdom.
Home Page: polarean.com
27-28 Eastcastle Street
London,
W1W 8DH
United Kingdom
Phone:
919 206 7900
Officers
| Name | Title |
|---|---|
| Dr. Kenneth Paul West Ph.D. | Chairman of the Board |
| Dr. Christopher Richard Von Jako Ph.D. | CEO & Director |
| Dr. Bastiaan Driehuys Ph.D. | Founder, Chief Scientific Officer & Director |
| Mr. Charles Fremont Osborne Jr. | CFO & Director |
| Mr. Neil Wadehra | Vice President of Operations |
| Mr. Alex Dusek | Chief Commercial Officer |
| Dr. Chase Hall M.D. | Chief Medical Advisor |
| Mr. Stephen Austin | Company Secretary |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Equipment |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.0404 |
| Price-to-Sales TTM: | 10.9266 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 29 |